Core Viewpoint - The company has announced a share repurchase program, believing its current share price does not reflect its business performance and growth potential in the aesthetic-medical market [2][3]. Share Repurchase Program - The company will repurchase shares starting May 20, 2025, with a maximum aggregate amount of US$5 million, funded by surplus cash and future free cash flow [7]. - The repurchase will be conducted in the open market at prevailing prices, including through Rule 10b5-1 plans [2]. - The company plans to issue shares as future stock-based compensation in proportion to the number of repurchased shares [2]. Financial Strategy - The company aims to balance growth investment with shareholder returns, considering dividend distributions to enhance total shareholder return [3]. - To allocate funds for the repurchase, the company will defer further purchases under its Bitcoin purchase plan, which targeted JPY1 billion [3]. Acquisition Plans - The company is reviewing the acquisition of all shares of Risenet Co., Ltd., which provides management-support services to its clinics [4]. - The acquisition details, including price and impact on consolidated financials, are yet to be determined [4]. Company Overview - SBC Medical, headquartered in Irvine, California, and Tokyo, Japan, provides management services and products to cosmetic treatment centers, focusing on franchise clinics [5]. - Services include advertising, staff management, customer booking, facility rentals, medical equipment procurement, and IT solutions [5].